CompletedPHASE1, PHASE2NCT00107770
Safety Study of Oral Sodium Phenylbutyrate in Subjects With ALS (Amyotrophic Lateral Sclerosis)
Studying Amyotrophic lateral sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- US Department of Veterans Affairs
- Principal Investigator
- Robert Ferrante, PhD MScEdith Nourse Rogers Memorial Veterans Hospital, Bedford
- Intervention
- sodium phenylbutyrate(drug)
- Enrollment
- 40 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2005 – 2007
Study locations (10)
- VA Medical Center, Iowa City, Iowa City, Iowa, United States
- VA Medical Center, Lexington, Lexington, Kentucky, United States
- VA Maryland Health Care System, Baltimore, Baltimore, Maryland, United States
- Edith Nourse Rogers Memorial Veterans Hospital, Bedford, Bedford, Massachusetts, United States
- VA Medical Center, Jamaica Plain Campus, Boston, Massachusetts, United States
- VA Medical Center, Syracuse, Syracuse, New York, United States
- VA Medical Center, Durham, Durham, North Carolina, United States
- VA Medical Center, Cincinnati, Cincinnati, Ohio, United States
- VA Pittsburgh Health Care System, Pittsburgh, Pennsylvania, United States
- Michael E. DeBakey VA Medical Center (152), Houston, Texas, United States
Collaborators
Muscular Dystrophy Association
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00107770 on ClinicalTrials.govOther trials for Amyotrophic lateral sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07401186Stimulation-Based Modulation of Spinal and Cortical Sensory PathwaysPeter C. Gerszten, MD
- RECRUITINGNCT07467187Invasive Home Ventilation in DenmarkRigshospitalet, Denmark
- RECRUITINGNCT07259980A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)Biogen
- RECRUITINGNCT07502677Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral SclerosisRoyal Brompton & Harefield NHS Foundation Trust
- RECRUITINGNANCT07446114Functional Outcomes and Control Using Synchron BCI - CanadaSynchron, Inc.
- ENROLLING BY INVITATIONPHASE2, PHASE3NCT07410806HEALEY ALS Platform Trial - Regimen I NUZ-001Merit E. Cudkowicz, MD
- ENROLLING BY INVITATIONNANCT07298486Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALSNova Southeastern University
- ACTIVE NOT RECRUITINGPHASE1NCT07204977Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)National Institute of Neurological Disorders and Stroke (NINDS)